Panacea Biotec Limited

NSE: PANACEABIO · Unclassified

₹344.00-3.03%06 Nov 2026

Ask the data

Instant answers about Panacea Biotec Limited — computed from its filings, no language model

Market cap₹2,109 cr

Current price₹344.00

High / Low₹608 / ₹296

P/E—

P/B2.53

Book value₹136.2

ROE-0.9%

ROCE-0.5%

Debt / equity0.03

Dividend yield—

EPS (TTM)₹-1.16

Face value₹1

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 7 periods

	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	544.1	624.8	661.2	459.9	559.2	559.1	639.8
EBITDA	31.4	76.6	-13.9	-98.0	-20.1	-25.9	-4.7
Operating margin	5.8%	12.3%	-2.1%	-21.3%	-3.6%	-4.6%	-0.7%
Interest	174.0	185.3	180.8	4.4	3.6	3.9	6.0
Depreciation	43.2	45.6	43.7	39.1	36.7	34.8	33.1
Profit before tax	-171.6	-144.3	1,448.8	12.8	1.5	-8.0	-7.4
Tax	16.6	2.0	370.9	46.5	3.0	0.8	-0.2
Net profit	-194.3	-147.7	1,077.9	0.0	-1.2	-8.4	-5.4
EPS ₹	-31.72	-24.11	175.98	-5.51	-0.19	-1.37	-0.88
Operating cash flow	—	—	-108.4	-423.5	-0.1	-27.4	16.7
Capex	—	—	12.5	41.0	77.7	50.3	54.1
Dividend paid	—	—	0.0	0.0	0.0	0.0	0.0
Total assets	—	—	—	1,271.2	1,240.7	1,289.8	1,262.2
Equity	—	—	—	843.6	842.0	834.8	834.8

Quarterly performance

last 29 quarters · ₹ crore

showing latest 8 of 29 periods

	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Revenue	125.8	125.2	167.7	125.4	132.8	182.0	141.8	168.3	132.4	232.2	155.9	140.7	110.7	105.1	115.2	128.9	129.2	143.0	150.5	136.5	115.7	147.3	163.5	132.5	166.7	141.1	165.2	166.8	199.6
Operating profit	23.4	-6.0	36.8	-22.9	22.5	38.0	15.2	0.9	-1.6	6.0	11.9	-30.2	-79.8	-3.8	-8.6	-5.7	-10.3	-3.6	-0.1	-6.0	-14.0	7.0	8.0	-26.9	-1.2	-17.8	11.7	2.6	5.7
Operating margin	18.6%	-4.8%	22.0%	-18.2%	17.0%	20.9%	10.7%	0.6%	-1.2%	2.6%	7.6%	-21.5%	-72.1%	-3.7%	-7.5%	-4.4%	-8.0%	-2.5%	-0.1%	-4.4%	-12.1%	4.8%	4.9%	-20.3%	-0.7%	-12.6%	7.1%	1.5%	2.8%
Other income	5.0	3.5	3.2	18.0	1.2	2.0	1.9	4.9	3.2	2.0	1.7	4.0	12.2	10.4	13.9	15.1	6.1	3.2	5.7	10.8	3.8	4.7	3.6	8.6	5.7	6.4	2.3	2.5	4.2
Interest	40.8	41.5	47.2	44.5	45.2	47.5	45.7	46.9	47.9	50.2	52.1	30.7	1.2	1.2	1.0	1.1	1.0	0.9	0.8	0.8	0.9	1.0	1.0	1.0	0.9	2.1	1.9	1.2	1.2
Depreciation	11.4	11.1	10.7	10.1	11.3	11.4	11.3	11.6	11.1	10.9	10.6	11.2	10.1	9.9	9.7	9.5	9.5	9.3	9.1	8.8	8.7	8.7	9.0	8.4	8.4	8.3	8.4	7.9	7.9
Profit before tax	-23.8	-70.5	-17.9	-59.4	-32.8	-18.9	-40.0	-52.6	-57.3	-53.0	-49.2	1,608.3	-51.2	23.3	22.4	18.2	13.0	-7.8	-1.6	-2.1	-17.1	4.8	4.4	-0.0	6.6	-19.2	6.5	-1.2	3.6
Tax	2.8	2.4	2.3	9.2	0.3	0.1	0.0	1.5	0.1	0.0	0.0	370.8	5.0	7.6	3.1	30.9	2.0	0.5	0.6	-0.1	-1.2	0.1	-0.1	1.9	2.6	-5.2	2.6	-0.2	1.4
Net profit	0.0	0.0	-21.3	-69.7	-34.1	-19.3	-40.0	-54.1	0.0	-53.0	0.0	1,237.5	-56.1	0.0	19.4	0.0	11.0	0.0	-2.2	-1.4	-15.8	4.8	4.5	-1.9	4.0	-13.9	4.0	0.5	2.3
EPS ₹	-4.62	-12.25	-3.48	-11.38	-5.58	-3.16	-6.54	-8.84	-9.36	-8.65	-8.03	202.03	-9.17	2.56	3.16	-2.07	1.79	-1.35	-0.37	-0.23	-2.59	0.77	0.74	-0.31	0.66	-2.27	0.65	0.08	0.38
Revenue YoY	—	—	—	—	5.5%	45.4%	-15.5%	34.2%	-0.2%	27.6%	10.0%	-16.4%	-16.4%	-54.7%	-26.1%	-8.4%	16.7%	36.1%	30.6%	5.8%	-10.4%	3.0%	8.6%	-2.9%	44.1%	-4.2%	1.0%	25.8%	19.7%
Profit YoY	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-100.0%	—	—	-111.4%	—	-243.9%	—	—	—	—	-390.0%	-11.9%	—	-43.2%

Earlier results (standalone, Sep '07 – Mar '19)

₹ crore · from BSE, before the NSE XBRL filings begin

Panacea Biotec Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 11 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†
Revenue	778.1	909.8	1,152.4	700.6	595.9	503.0	679.2	646.9	530.1	579.9	356.8
Operating profit	166.2	164.6	267.2	-46.1	-64.5	-91.7	66.3	111.8	68.6	81.4	-122.7
Operating margin	21.4%	18.1%	23.2%	-6.6%	-10.8%	-18.2%	9.8%	17.3%	12.9%	14.0%	-34.4%
Other income	23.5	5.4	13.1	7.5	5.4	188.7	28.1	25.6	52.3	17.6	11.9
Interest	32.1	38.3	47.8	86.0	110.2	148.6	95.1	114.3	101.4	103.2	104.6
Depreciation	70.5	66.4	73.1	75.4	83.5	68.8	65.7	71.3	65.7	57.0	49.3
Profit before tax	-92.4	118.1	155.5	-262.9	-250.6	-0.4	-63.3	1.4	-83.8	-61.2	69.3
Tax	-23.3	38.1	20.4	-55.1	-20.5	0.0	1.9	0.5	2.5	10.6	42.8
Net profit	-69.0	80.0	135.0	-207.8	-230.1	-0.4	-65.2	0.9	-86.2	-71.9	26.6

Quarters

showing latest 8 of 47 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†
Revenue	175.1	226.3	195.5	224.5	146.9	178.5	228.2	180.8	168.8	231.4	328.7	258.4	256.2	292.8	344.9	225.7	228.8	155.2	91.0	88.7	132.8	184.1	190.4	117.6	110.1	111.6	163.7	150.9	158.6	147.6	222.1	124.8	164.8	154.1	203.2	123.7	137.2	102.2	167.0	107.6	152.6	152.2	167.6	95.1	118.6	113.8	29.3
Operating profit	49.7	59.0	32.9	57.7	24.4	17.4	66.6	45.7	28.0	40.6	50.4	61.5	56.4	82.3	67.1	53.0	2.0	-28.8	-72.3	-18.7	-13.7	-12.7	-19.4	-9.1	0.7	-39.2	-44.0	31.0	13.7	7.4	14.2	7.8	25.0	23.2	55.8	10.7	10.2	-0.2	47.8	-7.2	36.9	30.3	21.5	-18.4	-10.3	17.3	-111.3
Operating margin	28.4%	26.1%	16.8%	25.7%	16.6%	9.8%	29.2%	25.3%	16.6%	17.5%	15.3%	23.8%	22.0%	28.1%	19.4%	23.5%	0.9%	-18.6%	-79.5%	-21.0%	-10.3%	-6.9%	-10.2%	-7.8%	0.6%	-35.1%	-26.9%	20.5%	8.6%	5.0%	6.4%	6.2%	15.2%	15.0%	27.5%	8.7%	7.5%	-0.2%	28.6%	-6.7%	24.2%	19.9%	12.8%	-19.3%	-8.7%	15.2%	-380.5%
Other income	8.7	0.6	15.0	7.5	6.3	6.2	3.4	1.3	1.2	1.1	1.7	1.3	4.1	3.1	4.6	1.7	1.0	2.0	2.8	0.1	0.0	2.6	2.7	0.2	0.2	177.7	10.6	0.3	5.4	6.1	16.3	3.7	7.4	6.0	8.6	11.2	20.0	13.7	7.4	1.2	1.8	1.9	12.7	3.3	3.3	4.1	1.1
Interest	2.1	4.7	3.8	4.8	6.0	10.7	10.5	9.8	10.0	8.6	9.9	8.6	11.4	12.6	15.3	16.3	14.7	16.4	38.6	41.2	7.6	27.0	34.4	33.1	38.6	39.8	37.1	39.4	10.4	1.6	43.8	29.8	31.7	28.5	24.3	25.0	25.5	26.3	24.6	25.9	26.5	25.1	25.7	26.1	26.8	28.2	23.5
Depreciation	10.0	11.2	12.6	13.7	15.0	15.4	26.4	16.1	16.2	16.4	17.8	17.4	18.5	18.3	19.0	16.3	20.0	19.4	19.7	20.0	20.9	21.6	21.0	19.0	18.5	15.9	15.4	15.4	15.6	18.5	16.2	18.6	17.7	18.1	17.0	16.6	16.6	16.4	16.1	14.4	14.4	14.5	13.8	13.7	13.6	13.6	8.4
Profit before tax	46.2	43.7	31.6	46.7	-32.3	-20.5	-86.2	21.1	3.0	16.7	77.2	35.4	28.6	56.0	35.5	20.7	-40.3	-73.4	-169.9	-79.8	-25.8	-62.3	-82.8	-60.9	-56.3	82.8	34.0	-23.5	-6.8	-3.5	-29.5	-36.9	-17.0	-17.4	72.7	-19.7	-11.8	-29.2	-23.0	-46.3	-2.2	-7.4	-5.3	-34.2	-94.8	-20.4	218.7
Tax	14.2	14.8	6.6	12.7	11.7	-1.7	-46.0	8.1	0.9	9.4	19.7	2.8	11.7	13.4	-7.5	4.0	-6.7	-1.6	-50.8	-13.8	-6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.5	1.7	3.4	2.3	3.2	2.7	2.7	2.7	34.8
Net profit	32.1	28.9	24.9	34.0	-44.1	-18.9	-40.2	13.0	2.1	7.3	57.5	32.5	16.9	42.6	43.0	16.7	-33.6	-71.7	-119.1	-66.0	-19.1	-62.3	-82.8	-60.9	-56.3	82.8	34.0	-23.5	-6.8	-3.5	-31.4	-36.9	-17.0	-17.4	72.2	-19.7	-11.8	-29.2	-25.5	-48.0	-5.6	-9.7	-8.6	-36.8	-97.5	-23.0	183.9
EPS ₹	4.88	4.39	3.77	5.11	-6.61	-2.83	-6.02	1.95	0.32	1.10	8.61	4.87	2.71	6.83	6.95	2.73	-5.49	-11.71	-19.46	-10.77	-3.12	-10.17	-13.51	-9.95	-9.18	13.51	5.55	-3.84	-1.11	-0.57	-5.12	-6.02	-2.77	-2.84	11.77	-3.21	-1.93	-4.77	-4.16	-7.84	-0.92	-1.58	-1.40	-6.01	-15.92	-3.76	30.02
Revenue YoY	—	—	—	—	-16.1%	-21.1%	16.7%	-19.4%	14.9%	29.6%	44.0%	42.9%	51.8%	26.5%	4.9%	-12.7%	-10.7%	-47.0%	-73.6%	-60.7%	-42.0%	18.7%	109.3%	32.6%	-17.1%	-39.4%	-14.0%	28.3%	44.0%	32.3%	35.7%	-17.3%	3.9%	4.4%	-8.5%	-0.9%	-16.8%	-33.7%	-17.8%	-13.0%	11.2%	48.8%	0.3%	-11.6%	-22.3%	-25.2%	-82.5%
Profit YoY	—	—	—	—	-237.3%	-165.2%	-261.3%	-61.7%	—	—	—	149.8%	692.0%	480.2%	-25.2%	-48.6%	-299.4%	-268.4%	-376.9%	-494.6%	—	—	—	—	—	—	—	—	—	-104.2%	-192.4%	—	—	—	—	—	—	—	-135.3%	—	—	—	—	—	—	—	—

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 26 periods

	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
ROE	—	—	—	—	—	—	—	—	—	—	146.2%	148.6%	-4.4%	3.6%	3.6%	1.0%	0.9%	-2.3%	-1.8%	-0.9%	-1.0%	1.4%	-0.9%	-0.9%	-0.6%	-0.9%
ROCE	—	—	—	—	—	—	—	—	—	—	192.3%	194.8%	2.0%	9.4%	5.7%	3.0%	0.6%	-2.9%	-1.5%	-0.7%	-0.5%	2.3%	-0.4%	-0.0%	-0.2%	-0.5%
Net margin	-16.7%	-22.7%	-23.8%	-28.0%	-23.6%	-18.2%	-21.8%	-15.6%	179.1%	176.4%	230.5%	254.5%	-8.0%	6.3%	5.9%	1.6%	1.3%	-3.6%	-2.7%	-1.4%	-1.5%	1.9%	-1.2%	-1.3%	-0.8%	-1.1%
EBITDA margin	5.8%	5.5%	12.3%	9.1%	12.3%	8.4%	3.0%	2.5%	-2.1%	-14.4%	-19.9%	-26.0%	-21.3%	-5.9%	-5.5%	-3.6%	-3.6%	-4.4%	-2.4%	-0.9%	-4.6%	-2.1%	-6.3%	-5.6%	-0.7%	0.3%
Debt / equity	—	—	—	—	—	—	—	—	—	—	0.04	0.04	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Interest coverage	0.01	-0.01	0.30	0.17	0.22	0.10	-0.06	-0.08	9.01	11.84	18.97	48.07	3.88	19.37	12.71	6.72	1.41	-7.29	-3.56	-1.74	-1.05	5.05	-0.64	-0.05	-0.22	-0.63
Asset turnover	—	—	—	—	—	—	—	—	—	—	0.38	0.35	0.36	0.38	0.41	0.43	0.45	0.44	0.44	0.45	0.43	0.47	0.48	0.48	0.51	0.53

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	6.1	6.1	6.1	6.1	6.1	6.1	6.1	6.1
Other equity / reserves	802.0	837.5	840.9	835.9	826.8	828.7	820.3	828.7
Total equity	808.1	843.6	847.0	842.0	832.9	834.8	826.4	834.8
Borrowings	32.3	20.2	20.7	21.0	21.6	22.2	22.9	23.7
Current liabilities	408.1	329.7	331.8	308.8	327.8	367.0	345.1	348.7
Non-current liabilities	135.4	99.2	97.0	93.6	86.3	92.1	87.4	84.6
Total assets	1,350.9	1,271.2	1,272.2	1,240.7	1,243.1	1,289.8	1,254.5	1,262.2
Property, plant & equipment	569.4	588.3	581.1	560.0	545.9	543.4	532.9	553.3
Capital work-in-progress	6.9	28.0	51.7	74.7	84.2	93.5	109.8	100.0
Investments	15.6	13.5	34.0	40.4	37.1	3.2	3.3	10.1
Inventories	194.5	202.1	199.9	177.9	166.8	213.7	195.3	192.8
Receivables	122.2	60.1	76.8	57.4	63.0	72.6	76.2	73.5
Cash & equivalents	42.7	39.9	37.0	47.2	47.7	82.1	63.7	57.3

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	-108.4	-423.5	-0.1	-27.4	16.7
Cash from investing	1,282.6	430.3	10.2	65.0	-40.5
Cash from financing	-1,175.8	-18.4	-2.8	-2.7	-1.1
Capex	12.5	41.0	77.7	50.3	54.1
Free cash flow	-120.9	-464.4	-77.8	-77.7	-37.4
Dividends paid	0.0	0.0	0.0	0.0	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹553.3 cr44%

CWIP

₹100.0 cr8%

Investments

₹10.1 cr1%

Inventories

₹192.8 cr15%

Receivables

₹73.5 cr6%

Cash & equivalents

₹57.3 cr5%

Other assets

₹275.2 cr22%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Panacea Biotec Limited	2,109	344.00	—	2.53	-0.9%

StoxGud checklist: Bearish setup · 3/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-3.8%

6 months-14.8%

1 year-22.3%

3Y CAGR+29.5%

5Y CAGR+10.5%

10Y CAGR+11.3%

50-day avg₹361.33

200-day avg₹398.14

RSI (14)45

FAQs

What is the share price of Panacea Biotec Limited?

Panacea Biotec Limited (PANACEABIO) closed at ₹344.00 on NSE on 06 Nov 2026.

What is the market cap of Panacea Biotec Limited?

₹2,109 crore at the latest close.

How fast is Panacea Biotec Limited growing?

Panacea Biotec Limited: revenue has compounded at 11.6% a year over three years. Latest-quarter revenue is up 19.7% year on year, profit down 43.2%.

How profitable is Panacea Biotec Limited?

On a trailing-twelve-month basis return on equity is -0.9%, return on capital employed -0.5%, operating margin 0.3%, net margin -1.1%.

How much debt does Panacea Biotec Limited have?

Panacea Biotec Limited is debt-free: debt to equity is 0.03 with borrowings of ₹24 cr against cash of ₹57 cr (balance sheet of 2026-03-31). Operating profit covers interest -0.6 times.

Financials parsed from Panacea Biotec Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '19, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.